Seres Therapeutics
MCRB
MCRB
79 hedge funds and large institutions have $344M invested in Seres Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.07% less ownership
Funds ownership: 3.85% → 3.78% (-0.07%)
11% less funds holding
Funds holding: 89 → 79 (-10)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
79
Holding in Top 10
1
Calls
$1.14M
Puts
$298K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$1.55M | |
| 3 | +$1.17M | |
| 4 |
SIM
Spark Investment Management
New York
|
+$613K |
| 5 |
JPMorgan Chase & Co
New York
|
+$573K |
Top Sellers
| 1 | -$3.55M | |
| 2 | -$1.6M | |
| 3 | -$1.13M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.07M |